Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
Archivos De Bronconeumologia|April 9, 2023
Relationship Between the Diffusing Capacity of the Lung for Carbon Monoxide (DLCO) and Lung Adenocarcinoma Patterns: New Possible InsightsLuigi Ventura, Letizia Gnetti, Gianluca Milanese, et al.
Tumori|December 16, 2024
Bridging bench to bedside: The evolution and impact of translational research in oncology. The experience of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC)Benedetta Pellegrino, Filippo Giovanardi, Carmelo Tibaldi, et al.
Journal for Immunotherapy of Cancer|January 6, 2026
Dissecting the impact of Controlling Nutritional Status (CONUT) score on survival outcomes and immune-inflammatory profiles in patients with advanced NSCLC undergoing first-line immunotherapyFederica Pecci, Giulia Mazzaschi, Alessandra Dodi, et al.
Clinical Lung Cancer|April 15, 2023
Salvage Surgery After First-Line Alectinib for Locally-Advanced/Metastatic ALK-Rearranged NSCLC: Pathological Response and Perioperative ResultsFilippo Lococo, Alessandra Cancellieri, Marco Chiappetta, et al.
The Journal of Liquid Biopsy|March 3, 2025
NGS detection of gene rearrangements and METexon14 mutations in liquid biopsy of advanced NSCLC patients: A study of two Italian centersMichela Verzè, Andrea Boscolo Bragadin, Roberta Minari, et al.
Cancer Treatment and Research Communications|November 3, 2019
Treatment Outcome of metastatic lesions from renal cell carcinoma underGoing Extra-cranial stereotactic body radioTHERapy: The together retrospective studySebastiano Buti, Melissa Bersanelli, Alessandro Viansone, et al.
International Journal of Nursing Sciences|June 18, 2025
Prevalence of central line-associated bloodstream infections in patients with cancer and subgroup analysis using propensity score matching: A nationwide multicenter study in ItalySilvia Belloni, Cristina Arrigoni, Marco Alfredo Arcidiacono, et al.
Immunotherapy|August 20, 2025
Prognostic immunoinflammatory and transcriptomic profiles in patients with pleural mesothelioma undergoing immunotherapyGiulia Mazzaschi, Roberto Rosati, Simona D'Agnelli, et al.
European Journal of Cancer (Oxford, England : 1990)|February 24, 2026
Real-world outcomes of immunotherapy discontinuation at two years in advanced non-small cell lung cancer: Final results of the I-STOP studyMaria Gemelli, Luca Sala, Alessandro Morabito, et al.
Biomedical Reports|January 14, 2020
Palliative radiotherapy in advanced cancer patients treated with immune-checkpoint inhibitors: The PRACTICE studyMelissa Bersanelli, Elisabetta Lattanzi, Nunziata D'Abbiero, et al.
Pageof 7